Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

ALS is the most common form of motor neurone disease (MND)

ALS is a fatal neurodegenerative disorder. It is characterized by progressive muscular paralysis reflecting the degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord.

Up to 5000

Adults in the UK are affected by MND at any one time

55 years

Average age of onset of ALS

Source: ALS Association 2021
1 in 300

Risk of getting MND across a lifetime


Zambon is committed to improving people’s quality of life

Thanks to a collaboration with Aquestive, Zambon further strengthened its commitment to orphan diseases and to the CNS area, enriching its portfolio with a new formulation that will help ALS patients. Zambon is committed to improving people’s quality of life through innovative medicines and modern therapeutic solutions where they are most needed.